Elon Musk’s Neuralink says FDA has given nod to kickstart first human trials

The US Food and Drug Administration (FDA) has approved Elon Musk’s brain-implant company Neuralink to begin its first-in-human clinical study.

The company announced the milestone in a Twitter post, which stated, “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.” However, the regulator is yet to comment on this. 

We are excited to share…